Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade.

What Was Tested

The paper reports a study of Gonadotropin-Releasing Hormone, published as a randomized controlled trial.

Testosterone (T) secretion declines in the aging male, albeit for unknown reasons.

From an ensemble perspective, repeated incremental signaling among gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), and T is required to maintain physiological androgen availability.

Who Took Part

According to the abstract, 25 men were involved.

The age groups tagged for this paper are adults, middle-aged adults and older adults, men only.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Because people in this Gonadotropin-Releasing Hormone study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the men and researchers unaware of who received Gonadotropin-Releasing Hormone.

The comparison arm used a placebo, so changes seen with Gonadotropin-Releasing Hormone could be set against what happens without it.

What Was Measured

Testosterone (T) secretion declines in the aging male, albeit for unknown reasons.

Pattern-regularity statistics, such as univariate approximate entropy (ApEn) and bivariate cross-ApEn, provide specific and sensitive model-free measurement of altered multi-pathway control.

Topics PubMed links to this paper include Age Factors, Aging, Analysis of Variance, Gonadotropin-Releasing Hormone, Hormone Antagonists, Leydig Cells and Luteinizing Hormone.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Gonadotropin-Releasing Hormone in 25 men.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2006 (American journal of physiology. Endocrinology and metabolism), a journal based in United States.

More context: all human trials.